Human islet amyloid polypeptide: A therapeutic target for the management of type 2 diabetes mellitus

Kalin, 2017, Pathogenesis of type 2 diabetes mellitus, 267 Cerf, 2013, Beta cell dysfunction and insulin resistance (Lausanne), Front. Endocrinol., 4, 10.3389/fendo.2013.00037 Baena-Díez, 2016, Risk of cause-specific death in individuals with diabetes: A competing risks analysis, Diabetes Care, 39, 1987, 10.2337/dc16-0614 Amod, 2020, Risk factors for kidney disorders in patients with type 2 diabetes at high cardiovascular risk: An exploratory analysis (DEVOTE 12), Diabetes Vasc. Dis. Res., 17, 10.1177/1479164120970933 Tsegaw, 2021, Diabetic retinopathy in type 2 diabetes mellitus patients attending the diabetic clinic of the University of Gondar Hospital, Northwest Ethiopia, J. Ophthalmol., 2021 Li, 2019, Diabetes mellitus and risk of hepatic fibrosis/cirrhosis, Biomed. Res. Int., 2019 Sun, 2021, IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045, Diabetes Res. Clin. Pract., 183 Spurr, 2020, Exploring the prevalence of undiagnosed prediabetes, type 2 diabetes mellitus, and risk factors in adolescents: A systematic review, J. Pediatr. Nurs., 50, 94, 10.1016/j.pedn.2019.09.025 Eaton, 2017, Physical inactivity, obesity, and type 2 diabetes: An evolutionary perspective, Res. Q. Exerc. Sport, 88, 1, 10.1080/02701367.2016.1268519 Lin, 2020, Global, regional, and national burden and trend of diabetes in 195 countries and territories: An analysis from 1990 to 2025, Sci. Rep., 10 Jaikaran, 2001, Islet amyloid and type 2 diabetes: From molecular misfolding to islet pathophysiology, Biochim. Biophys. Acta, 1537, 179, 10.1016/S0925-4439(01)00078-3 Kanatsuka, 2018, IAPP/amylin and β-cell failure: Implication of the risk factors of type 2 diabetes, Diabetol. Int., 9, 143, 10.1007/s13340-018-0347-1 Weir, 2020, Glucolipotoxicity, β-cells, and diabetes: The emperor has no clothes, Diabetes, 69, 273, 10.2337/db19-0138 Saisho, 2015, β-cell dysfunction: Its critical role in prevention and management of type 2 diabetes, World J. Diabetes, 6, 109, 10.4239/wjd.v6.i1.109 Petersen, 2018, Mechanisms of insulin action and insulin resistance, Physiol. Rev., 98, 2133, 10.1152/physrev.00063.2017 Westermark, 2011, Islet amyloid polypeptide, islet amyloid, and diabetes mellitus, Physiol. Rev., 91, 795, 10.1152/physrev.00042.2009 Zhang, 2016, Neuroendocrine hormone amylin in diabetes, World J. Diabetes, 7, 189, 10.4239/wjd.v7.i9.189 Hay, 2015, Amylin: Pharmacology, physiology, and clinical potential, Pharmacol. Rev., 67, 564, 10.1124/pr.115.010629 Röder, 2016, Pancreatic regulation of glucose homeostasis, Exp. Mol. Med., 48, 10.1038/emm.2016.6 Tokuyama, 1997, Expression of human islet amyloid polypeptide/amylin impairs insulin secretion in mouse pancreatic beta cells, Metabolism, 46, 1044, 10.1016/S0026-0495(97)90276-6 Jeffrey, 2008, Carboxypeptidase E mediates palmitate-induced beta-cell ER stress and apoptosis, Proc. Natl. Acad. Sci. U S A, 105, 8452, 10.1073/pnas.0711232105 Paulsson, 2005, Aberrant processing of human proislet amyloid polypeptide results in increased amyloid formation, Diabetes, 54, 2117, 10.2337/diabetes.54.7.2117 Gurlo, 2010, Evidence for proteotoxicity in beta cells in type 2 diabetes: Toxic islet amyloid polypeptide oligomers form intracellularly in the secretory pathway, Am. J. Pathol., 176, 861, 10.2353/ajpath.2010.090532 Pirarat, 2008, Spontaneous diabetes mellitus in captive Mandrillus sphinx monkeys: A case report, J. Med. Primatol., 37, 162, 10.1111/j.1600-0684.2007.00274.x Arslan, 2007, Spontaneous amyloidosis and diabetes mellitus in a rhesus macaque (Macaca mulatta), Bull. Vet. Inst. Pulawy, 51, 655 Mukherjee, 2015, Type 2 diabetes as a protein misfolding disease, Trends Mol. Med., 21, 439, 10.1016/j.molmed.2015.04.005 Werner, 2020, Crosstalk between alpha-synuclein and other human and non-human amyloidogenic proteins: Consequences for amyloid formation in Parkinson’s disease, J. Parkinsons Dis., 10, 819, 10.3233/JPD-202085 Verma, 2020, Diabetic microcirculatory disturbances and pathologic erythropoiesis are provoked by deposition of amyloid-forming amylin in red blood cells and capillaries, Kidney Int., 97, 143, 10.1016/j.kint.2019.07.028 Liu, 2016, Hyperamylinemia increases IL-1β synthesis in the heart via peroxidative sarcolemmal injury, Diabetes, 65, 2772, 10.2337/db16-0044 Despa, 2012, Hyperamylinemia contributes to cardiac dysfunction in obesity and diabetes: A study in humans and rats, Circ. Res., 110, 598, 10.1161/CIRCRESAHA.111.258285 Gong, 2007, Amylin deposition in the kidney of patients with diabetic nephropathy, Kidney Int., 72, 213, 10.1038/sj.ki.5002305 Schultz, 2018, Levels of retinal IAPP are altered in Alzheimer's disease patients and correlate with vascular changes and hippocampal IAPP levels, Neurobiol. Aging, 69, 94, 10.1016/j.neurobiolaging.2018.05.003 Raimundo, 2020, Islet amyloid polypeptide: A partner in crime with Aβ in the pathology of Alzheimer’s disease, Front. Mol. Neurosci., 13, 10.3389/fnmol.2020.00035 Yoon, 2003, Selective β-cell loss and α-cell expansion in patients with type 2 diabetes mellitus in Korea, J. Clin. Endocrinol. Metab., 88, 2300, 10.1210/jc.2002-020735 Sakuraba, 2002, Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients, Diabetologia, 45, 85, 10.1007/s125-002-8248-z Rahier, 2008, Pancreatic β-cell mass in European subjects with type 2 diabetes, Diabetes Obes. Metabol., 10, 32, 10.1111/j.1463-1326.2008.00969.x Hanley, 2010, β-cell mass dynamics and islet cell plasticity in human type 2 diabetes, Endocrinology, 151, 1462, 10.1210/en.2009-1277 Butler, 2003, β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes, Diabetes, 52, 102, 10.2337/diabetes.52.1.102 Russo, 2014, Factors associated with beta-cell dysfunction in type 2 diabetes: The BETADECLINE study, PLoS One, 9, 10.1371/journal.pone.0109702 Levy, 1998, Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in type 2 diabetes mellitus: The 10-year follow-up of the Belfast Diet Study, Diabet. Med., 15, 290, 10.1002/(SICI)1096-9136(199804)15:4<290::AID-DIA570>3.0.CO;2-M Brereton, 2016, β-Cell dysfunction in diabetes: A crisis of identity?, Diabetes Obes. Metabol., 18, 102, 10.1111/dom.12732 Howard, 1986, Longitudinal studies on the development of diabetes in individual Macaca nigra, Diabetologia, 29, 301, 10.1007/BF00452067 Ma, 1998, Quantitative immunohistochemical analysis of islet amyloid polypeptide (IAPP) in normal, impaired glucose tolerant, and diabetic cats, Amyloid, 5, 255, 10.3109/13506129809007298 Jurgens, 2011, β-cell loss and β-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition, Am. J. Pathol., 178, 2632, 10.1016/j.ajpath.2011.02.036 Clark, 1988, Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: Quantitative changes in the pancreas in type 2 diabetes, Diabetes Res., 9, 151 Qiao, 2013, Dynamics of an intrinsically disordered protein reveal metastable conformations that potentially seed aggregation, J. Am. Chem. Soc., 135, 16092, 10.1021/ja403147m Higham, 2000, Processing of synthetic pro-islet amyloid polypeptide (proIAPP) ‘amylin’ by recombinant prohormone convertase enzymes, PC2 and PC3, in vitro, Eur. J. Biochem., 267, 4998, 10.1046/j.1432-1327.2000.01548.x Akter, 2016, Islet amyloid polypeptide: Structure, function, and pathophysiology, J. Diabetes Res., 2016 Rhoades, 2000, Aggregation of an amyloidogenic fragment of human islet amyloid polypeptide, Biochim. Biophys. Acta, 1476, 230, 10.1016/S0167-4838(99)00248-4 Abedini, 2016, Time-resolved studies define the nature of toxic IAPP intermediates, providing insight for anti-amyloidosis therapeutics, Elife, 5, 10.7554/eLife.12977 Sun, 2019, Amyloid self-assembly of hIAPP8-20 via the accumulation of helical oligomers, α-helix to β-sheet transition, and formation of β-barrel intermediates, Small, 15 Sun, 2019, Nucleation of β-rich oligomers and β-barrels in the early aggregation of human islet amyloid polypeptide, Biochim. Biophys. Acta Mol. Basis Dis., 1865, 434, 10.1016/j.bbadis.2018.11.021 Patil, 2011, Heterogeneous amylin fibril growth mechanisms imaged by total internal reflection fluorescence microscopy, Biochemistry, 50, 2808, 10.1021/bi101908m Padrick, 2002, Islet amyloid: Phase partitioning and secondary nucleation are central to the mechanism of fibrillogenesis, Biochemistry, 41, 4694, 10.1021/bi0160462 Kayed, 1999, Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro, J. Mol. Biol., 287, 781, 10.1006/jmbi.1999.2646 Rambaran, 2008, Amyloid fibrils: Abnormal protein assembly, Prion, 2, 112, 10.4161/pri.2.3.7488 Bishoyi, 2020, Human islet amyloid polypeptide (hIAPP) - a curse in type II diabetes mellitus: Insights from structure and toxicity studies, Biol. Chem., 402, 133, 10.1515/hsz-2020-0174 Faridi, 2018, Mitigating human IAPP amyloidogenesis in vivo with chiral silica nanoribbons, Small, 14, 10.1002/smll.201802825 Haataja, 2008, Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis, Endocr. Rev., 29, 303, 10.1210/er.2007-0037 Mukherjee, 2017, Induction of IAPP amyloid deposition and associated diabetic abnormalities by a prion-like mechanism, J. Exp. Med., 214, 2591, 10.1084/jem.20161134 Huang, 2007, Induction of endoplasmic reticulum stress-induced beta-cell apoptosis and accumulation of polyubiquitinated proteins by human islet amyloid polypeptide, Am. J. Physiol. Endocrinol. Metab., 293, E1656, 10.1152/ajpendo.00318.2007 Zraika, 2009, Oxidative stress is induced by islet amyloid formation and time-dependently mediates amyloid-induced beta cell apoptosis, Diabetologia, 52, 626, 10.1007/s00125-008-1255-x Li, 2011, Involvement of mitochondrial dysfunction in human islet amyloid polypeptide-induced apoptosis in INS-1E pancreatic beta cells: An effect attenuated by phycocyanin, Int. J. Biochem. Cell Biol., 43, 525, 10.1016/j.biocel.2010.12.008 Westwell-Roper, 2011, IL-1 blockade attenuates islet amyloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction, J. Immunol., 187, 2755, 10.4049/jimmunol.1002854 Rivera, 2011, Human-IAPP disrupts the autophagy/lysosomal pathway in pancreatic β-cells: Protective role of p62-positive cytoplasmic inclusions, Cell Death Differ., 18, 415, 10.1038/cdd.2010.111 Scheuner, 2008, The unfolded protein response: A pathway that links insulin demand with beta-cell failure and diabetes, Endocr. Rev., 29, 317, 10.1210/er.2007-0039 Costes, 2011, β-cell dysfunctional ERAD/ubiquitin/proteasome system in type 2 diabetes mediated by islet amyloid polypeptide-induced UCH-L1 deficiency, Diabetes, 60, 227, 10.2337/db10-0522 Cadavez, 2014, Chaperones ameliorate beta cell dysfunction associated with human islet amyloid polypeptide overexpression, PLoS One, 9, 10.1371/journal.pone.0101797 Costes, 2014, UCHL1 deficiency exacerbates human islet amyloid polypeptide toxicity in β-cells: Evidence of interplay between the ubiquitin/proteasome system and autophagy, Autophagy, 10, 1004, 10.4161/auto.28478 Ly, 2017, Oxidative stress and calcium dysregulation by palmitate in type 2 diabetes, Exp. Mol. Med., 49, 10.1038/emm.2016.157 Del Guerra, 2005, Functional and molecular defects of pancreatic islets in human type 2 diabetes, Diabetes, 54, 727, 10.2337/diabetes.54.3.727 Dubey, 2017, Recombinant human islet amyloid polypeptide forms shorter fibrils and mediates β-cell apoptosis via generation of oxidative stress, Biochem. J., 474, 3915, 10.1042/BCJ20170323 Montemurro, 2019, IAPP toxicity activates HIF1α/PFKFB3 signaling delaying β-cell loss at the expense of β-cell function, Nat. Commun., 10 Hayden, 2002, Islet redox stress: The manifold toxicities of insulin resistance, metabolic syndrome and amylin derived islet amyloid in type 2 diabetes mellitus, JOP, 3, 86 Singh, 2018, Apoptosis signal regulating kinase-1 and NADPH oxidase mediate human amylin evoked redox stress and apoptosis in pancreatic beta-cells, Biochim. Biophys. Acta Biomembr., 1860, 1721, 10.1016/j.bbamem.2018.03.024 Rivera, 2014, Autophagy defends pancreatic β cells from human islet amyloid polypeptide-induced toxicity, J. Clin. Invest., 124, 3489, 10.1172/JCI71981 Konarkowska, 2005, Thiol reducing compounds prevent human amylin-evoked cytotoxicity, FEBS J., 272, 4949, 10.1111/j.1742-4658.2005.04903.x Sciacca, 2013, Cations as switches of amyloid-mediated membrane disruption mechanisms: Calcium and IAPP, Biophys. J., 104, 173, 10.1016/j.bpj.2012.11.3811 Liu, 2020, Oligomannuronate prevents mitochondrial dysfunction induced by IAPP in RINm5F islet cells by inhibition of JNK activation and cell apoptosis, Chin. Med., 15, 10.1186/s13020-020-00310-4 Hernández, 2018, Pancreatic β cells overexpressing hIAPP impaired mitophagy and unbalanced mitochondrial dynamics, Cell Death Dis., 9, 10.1038/s41419-018-0533-x Borchi, 2013, Mild exposure of RIN-5F β-cells to human islet amyloid polypeptide aggregates upregulates antioxidant enzymes via NADPH oxidase-RAGE: An hormetic stimulus, Redox Biol., 2, 114, 10.1016/j.redox.2013.12.005 Fernández, 2014, Human IAPP amyloidogenic properties and pancreatic β-cell death, Cell Calcium, 56, 416, 10.1016/j.ceca.2014.08.011 Park, 2014, The role of caspase-8 in amyloid-induced beta cell death in human and mouse islets, Diabetologia, 57, 765, 10.1007/s00125-013-3152-1 Morita, 2011, Autophagy protects against human islet amyloid polypeptide-associated apoptosis, J. Diabetes Investig., 2, 48, 10.1111/j.2040-1124.2010.00065.x Shigihara, 2014, Human IAPP-induced pancreatic β cell toxicity and its regulation by autophagy, J. Clin. Invest., 124, 3634, 10.1172/JCI69866 Kim, 2014, Amyloidogenic peptide oligomer accumulation in autophagy-deficient β cells induces diabetes, J. Clin. Invest., 124, 3311, 10.1172/JCI69625 Kamata, 2014, Islet amyloid with macrophage migration correlates with augmented β-cell deficits in type 2 diabetic patients, Amyloid, 21, 191, 10.3109/13506129.2014.937857 Masters, 2010, Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes, Nat. Immunol., 11, 897, 10.1038/ni.1935 Meier, 2014, Islet amyloid formation is an important determinant for inducing islet inflammation in high-fat-fed human IAPP transgenic mice, Diabetologia, 57, 1884, 10.1007/s00125-014-3304-y de Koning, 1998, Macrophages and pancreatic islet amyloidosis, Amyloid, 5, 247, 10.3109/13506129809007297 Westwell-Roper, 2014, Resident macrophages mediate islet amyloid polypeptide-induced islet IL-1β production and β-cell dysfunction, Diabetes, 63, 1698, 10.2337/db13-0863 Westwell-Roper, 2016, Differential activation of innate immune pathways by distinct islet amyloid polypeptide (IAPP) aggregates, J. Biol. Chem., 291, 8908, 10.1074/jbc.M115.712455 Westwell-Roper, 2015, IL-1 mediates amyloid-associated islet dysfunction and inflammation in human islet amyloid polypeptide transgenic mice, Diabetologia, 58, 575, 10.1007/s00125-014-3447-x Park, 2017, Dual role of interleukin-1β in islet amyloid formation and its β-cell toxicity: Implications for type 2 diabetes and islet transplantation, Diabetes Obes. Metab., 19, 682, 10.1111/dom.12873 Balcazar Morales, 2012, Role of AKT/mTORC1 pathway in pancreatic β-cell proliferation, Colomb. Med. (Cali), 43, 235, 10.25100/cm.v43i3.783 Dickson, 2004, Pancreatic β-cell growth and survival in the onset of type 2 diabetes: A role for protein kinase B in the Akt?, Am. J. Physiol. Endocrinol. Metab., 287, E192, 10.1152/ajpendo.00031.2004 Zhang, 2018, Amyloid formation reduces protein kinase B phosphorylation in primary islet β-cells which is improved by blocking IL-1β signaling, PLoS One, 13 Seeliger, 2013, Cosolvent effects on the fibrillation reaction of human IAPP, Phys. Chem. Chem. Phys., 15, 8902, 10.1039/c3cp44412k Bag, 2013, Membrane destabilization by monomeric hIAPP observed by imaging fluorescence correlation spectroscopy, Chem. Commun. (Camb), 49, 9155, 10.1039/c3cc44880k Pilkington, 2016, Pancreatic β-cell membrane fluidity and toxicity induced by human islet amyloid polypeptide species, Sci. Rep., 6, 10.1038/srep21274 Zhang, 2017, Islet amyloid polypeptide membrane interactions: Effects of membrane composition, Biochemistry, 56, 376, 10.1021/acs.biochem.6b01016 Sciacca, 2018, Amyloid growth and membrane damage: Current themes and emerging perspectives from theory and experiments on Aβ and hIAPP, Biochim. Biophys. Acta Biomembr., 1860, 1625, 10.1016/j.bbamem.2018.02.022 Gao, 2015, The effects of lipid membranes, crowding and osmolytes on the aggregation, and fibrillation propensity of human IAPP, J. Diabetes Res., 2015 Zhang, 2017, Membrane interactions of hIAPP monomer and oligomer with lipid membranes by molecular dynamics simulations, ACS Chem. Neurosci., 8, 1789, 10.1021/acschemneuro.7b00160 Lee, 2012, How type II diabetes-related islet amyloid polypeptide damages lipid bilayers, Biophys. J., 102, 1059, 10.1016/j.bpj.2012.01.039 Poojari, 2013, Membrane permeation induced by aggregates of human islet amyloid polypeptides, Biophys. J., 105, 2323, 10.1016/j.bpj.2013.09.045 Last, 2013, Common mechanism unites membrane poration by amyloid and antimicrobial peptides, Proc. Natl. Acad. Sci. U S A, 110, 6382, 10.1073/pnas.1219059110 Green, 2004, Atomic force microscopy reveals defects within mica supported lipid bilayers induced by the amyloidogenic human amylin peptide, J. Mol. Biol., 342, 877, 10.1016/j.jmb.2004.07.052 Engel, 2008, Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane, Proc. Natl. Acad. Sci. U S A, 105, 6033, 10.1073/pnas.0708354105 Brender, 2007, Membrane fragmentation by an amyloidogenic fragment of human islet amyloid polypeptide detected by solid-state NMR spectroscopy of membrane nanotubes, Biochim. Biophys. Acta, 1768, 2026, 10.1016/j.bbamem.2007.07.001 Sparr, 2004, Islet amyloid polypeptide-induced membrane leakage involves uptake of lipids by forming amyloid fibers, FEBS Lett., 577, 117, 10.1016/j.febslet.2004.09.075 Sciacca, 2008, Calcium-activated membrane interaction of the islet amyloid polypeptide: Implications in the pathogenesis of type II diabetes mellitus, Arch. Biochem. Biophys., 477, 291, 10.1016/j.abb.2008.06.018 Trikha, 2011, Clustering and internalization of toxic amylin oligomers in pancreatic cells require plasma membrane cholesterol, J. Biol. Chem., 286, 36086, 10.1074/jbc.M111.240762 Mo, 2018, Lipid accelerating the fibril of islet amyloid polypeptide aggravated the pancreatic islet injury in vitro and in vivo, Lipids Health Dis., 17, 10.1186/s12944-018-0694-8 O'Brien, 1994, Islet amyloid polypeptide in human insulinomas. Evidence for intracellular amyloidogenesis, Diabetes, 43, 329, 10.2337/diab.43.2.329 Stendahl, 2009, Extracellular matrix in pancreatic islets: Relevance to scaffold design and transplantation, Cell Transplant., 18, 1, 10.3727/096368909788237195 Potter-Perigo, 2003, Proteoglycans synthesized and secreted by pancreatic islet beta-cells bind amylin, Arch. Biochem. Biophys., 413, 182, 10.1016/S0003-9861(03)00116-4 Oskarsson, 2015, Heparan sulfate proteoglycans are important for islet amyloid formation and islet amyloid polypeptide-induced apoptosis, J. Biol. Chem., 290, 15121, 10.1074/jbc.M114.631697 Jha, 2011, Mechanism of amylin fibrillization enhancement by heparin, J. Biol. Chem., 286, 22894, 10.1074/jbc.M110.215814 Potter, 2015, Amyloid formation in human islets is enhanced by heparin and inhibited by heparinase, Am. J. Transplant., 15, 1519, 10.1111/ajt.13134 Castillo, 1998, Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation, Diabetes, 47, 612, 10.2337/diabetes.47.4.612 Gharibyan, 2020, Apolipoprotein E interferes with IAPP aggregation and protects pericytes from IAPP-induced toxicity, Biomolecules, 10, 10.3390/biom10010134 Al-Dalaeen, 2018, Advanced glycation end products: Mechanisms in the pathogenesis of type 2 diabetes and its complications, J. Res. Diabetes Metab., 4, 16 Kapurniotu, 1998, Contribution of advanced glycosylation to the amyloidogenicity of islet amyloid polypeptide, Eur. J. Biochem., 251, 208, 10.1046/j.1432-1327.1998.2510208.x Hsu, 2019, Protein glycation by glyoxal promotes amyloid formation by islet amyloid polypeptide, Biophys. J., 116, 2304, 10.1016/j.bpj.2019.05.013 Ma, 2019, Glycated insulin exacerbates the cytotoxicity of human islet amyloid polypeptides: A vicious cycle in type 2 diabetes, ACS Chem. Biol., 14, 486, 10.1021/acschembio.8b01128 Abedini, 2018, RAGE binds preamyloid IAPP intermediates and mediates pancreatic β cell proteotoxicity, J. Clin. Invest., 128, 682, 10.1172/JCI85210 Marín-Peñalver, 2016, Update on the treatment of type 2 diabetes mellitus, World J. Diabetes, 7, 354, 10.4239/wjd.v7.i17.354 Kupsal, 2016, Metformin combinatorial therapy for type 2 diabetes mellitus, J. Metab. Syndrome, 5 Kahn, 2006, Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy, N. Engl. J. Med., 355, 2427, 10.1056/NEJMoa066224 Ahmad, 2014, Insulin sources and types: A review of insulin in terms of its mode on diabetes mellitus, J. Tradit. Chin. Med., 34, 234, 10.1016/S0254-6272(14)60084-4 Rochester, 2014, Novel and emerging diabetes mellitus drug therapies for the type 2 diabetes patient, World J. Diabetes, 5, 305, 10.4239/wjd.v5.i3.305 Aref, 2019, Pancreatic transplantation: Brief review of the current evidence, World J. Transplant., 9, 81, 10.5500/wjt.v9.i4.81 Potter, 2010, Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts, Proc. Natl. Acad. Sci. U S A, 107, 4305, 10.1073/pnas.0909024107 Andersson, 2008, Amyloid deposition in transplanted human pancreatic islets: A conceivable cause of their long-term failure, Exp. Diabetes Res., 2008, 10.1155/2008/562985 Meier, 2006, Inhibition of human IAPP fibril formation does not prevent β-cell death: Evidence for distinct actions of oligomers and fibrils of human IAPP, Am. J. Physiol. Endocrinol. Metab., 291, E1317, 10.1152/ajpendo.00082.2006 Hull, 2005, Long-term treatment with rosiglitazone and metformin reduces the extent of, but does not prevent, islet amyloid deposition in mice expressing the gene for human islet amyloid polypeptide, Diabetes, 54, 2235, 10.2337/diabetes.54.7.2235 Matveyenko, 2009, Beneficial endocrine but adverse exocrine effects of sitagliptin in the human islet amyloid polypeptide transgenic rat model of type 2 diabetes: Interactions with metformin, Diabetes, 58, 1604, 10.2337/db09-0058 Fortin, 2016, Inhibition of islet amyloid polypeptide aggregation and associated cytotoxicity by nonsteroidal anti-inflammatory drugs, Can. J. Physiol. Pharmacol., 94, 35, 10.1139/cjpp-2015-0117 Xu, 2019, Regulation of artemisinin and its derivatives on the assembly behavior and cytotoxicity of amyloid polypeptides hIAPP and Aβ, ACS Chem. Neurosci., 10, 4522, 10.1021/acschemneuro.9b00385 Xu, 2020, Tetracycline derivatives resist the assembly behavior of human islet amyloid polypeptide, Biochimie, 174, 95, 10.1016/j.biochi.2020.04.012 Lu, 2021, Identification of crocin as a new hIAPP amyloid inhibitor via a simple yet highly biospecific screening system, Chem. Biodivers., 18, 10.1002/cbdv.202100270 Rojas, 2013, Metformin: An old but still the best treatment for type 2 diabetes, Diabetol. Metab. Syndrome, 5, 10.1186/1758-5996-5-6 Chen, 2009, Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer’s amyloid peptides via up-regulating BACE1 transcription, Proc. Natl. Acad. Sci. U S A, 106, 3907, 10.1073/pnas.0807991106 Son, 2016, Metformin facilitates amyloid-β generation by β- and γ-secretases via autophagy activation, J. Alzheimers Dis., 51, 1197, 10.3233/JAD-151200 Nedumpully-Govindan, 2015, Inhibition of IAPP aggregation by insulin depends on the insulin oligomeric state regulated by zinc ion concentration, Sci. Rep., 5, 10.1038/srep08240 Cui, 2009, Insulin is a kinetic but not a thermodynamic inhibitor of amylin aggregation, FEBS J., 276, 3365, 10.1111/j.1742-4658.2009.07061.x Khemtemourian, 2021, Investigation of the effects of two major secretory granules components, insulin and zinc, on human-IAPP amyloid aggregation and membrane damage, Chem. Phys. Lipids, 237, 10.1016/j.chemphyslip.2021.105083 Bennett, 2000, Degradation of amylin by insulin-degrading enzyme, J. Biol. Chem., 275, 36621, 10.1074/jbc.M006170200 Sladek, 2007, A genome-wide association study identifies novel risk loci for type 2 diabetes, Nature, 445, 881, 10.1038/nature05616 Zeggini, 2007, Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes, Science, 316, 1336, 10.1126/science.1142364 Bennett, 2003, An insulin-degrading enzyme inhibitor decreases amylin degradation, increases amylin-induced cytotoxicity, and increases amyloid formation in insulinoma cell cultures, Diabetes, 52, 2315, 10.2337/diabetes.52.9.2315 Zraika, 2010, Neprilysin impedes islet amyloid formation by inhibition of fibril formation rather than peptide degradation, J. Biol. Chem., 285, 18177, 10.1074/jbc.M109.082032 Guan, 2012, Degradation of islet amyloid polypeptide by neprilysin, Diabetologia, 55, 2989, 10.1007/s00125-012-2678-y Zraika, 2007, Identification of the amyloid-degrading enzyme neprilysin in mouse islets and potential role in islet amyloidogenesis, Diabetes, 56, 304, 10.2337/db06-0430 Yan, 2006, Design of a mimic of nonamyloidogenic and bioactive human islet amyloid polypeptide (IAPP) as nanomolar affinity inhibitor of IAPP cytotoxic fibrillogenesis, Proc. Natl. Acad. Sci. U S A, 103, 2046, 10.1073/pnas.0507471103 Schmitz, 2004, Amylin agonists: A novel approach in the treatment of diabetes, Diabetes, 53, S233, 10.2337/diabetes.53.suppl_3.S233 Bower, 2016, Amylin structure-function relationships and receptor pharmacology: Implications for amylin mimetic drug development, Br. J. Pharmacol., 173, 1883, 10.1111/bph.13496 Wang, 2015, Analysis of the ability of pramlintide to inhibit amyloid formation by human islet amyloid polypeptide reveals a balance between optimal recognition and reduced amyloidogenicity, Biochemistry, 54, 6704, 10.1021/acs.biochem.5b00567 Mack, 2010, Davalintide (AC2307), a novel amylin-mimetic peptide: Enhanced pharmacological properties over native amylin to reduce food intake and body weight, Int. J. Obes. (Lond), 34, 385, 10.1038/ijo.2009.238 Witkamp, 2011, Current and future drug targets in weight management, Pharm. Res., 28, 1792, 10.1007/s11095-010-0341-1 Scrocchi, 2002, Design of peptide-based inhibitors of human islet amyloid polypeptide fibrillogenesis, J. Mol. Biol., 318, 697, 10.1016/S0022-2836(02)00164-X Rijkers, 2002, Inhibition of amyloid fibril formation of human amylin by N-alkylated amino acid and α-hydroxy acid residue containing peptides, Chemistry, 8, 4285, 10.1002/1521-3765(20020916)8:18<4285::AID-CHEM4285>3.0.CO;2-0 Kapurniotu, 2002, Structure-based design and study of non-amyloidogenic, double N-methylated IAPP amyloid core sequences as inhibitors of IAPP amyloid formation and cytotoxicity, J. Mol. Biol., 315, 339, 10.1006/jmbi.2001.5244 Porat, 2004, Inhibition of islet amyloid polypeptide fibril formation: A potential role for heteroaromatic interactions, Biochemistry, 43, 14454, 10.1021/bi048582a Gilead, 2004, Inhibition of amyloid fibril formation by peptide analogues modified with α-aminoisobutyric acid, Angew. Chem. Int. Ed. Engl., 116, 4133, 10.1002/ange.200353565 Tatarek-Nossol, 2005, Inhibition of hIAPP amyloid-fibril formation and apoptotic cell death by a designed hIAPP amyloid- core-containing hexapeptide, Chem. Biol., 12, 797, 10.1016/j.chembiol.2005.05.010 Abedini, 2007, A single-point mutation converts the highly amyloidogenic human islet amyloid polypeptide into a potent fibrillization inhibitor, J. Am. Chem. Soc., 129, 11300, 10.1021/ja072157y Potter, 2009, Amyloid inhibitors enhance survival of cultured human islets, Biochim. Biophys. Acta, 1790, 566, 10.1016/j.bbagen.2009.02.013 Wijesekara, 2015, Islet amyloid inhibitors improve glucose homeostasis in a transgenic mouse model of type 2 diabetes, Diabetes Obes. Metabol., 17, 1003, 10.1111/dom.12529 Cao, 2010, The ability of rodent islet amyloid polypeptide to inhibit amyloid formation by human islet amyloid polypeptide has important implications for the mechanism of amyloid formation and the design of inhibitors, Biochemistry, 49, 872, 10.1021/bi901751b Muthusamy, 2010, Design and study of peptide-based inhibitors of amylin cytotoxicity, Bioorg. Med. Chem. Lett, 20, 1360, 10.1016/j.bmcl.2010.01.004 Huggins, 2011, Designed hairpin peptides interfere with amyloidogenesis pathways: Fibril formation and cytotoxicity inhibition, interception of the preamyloid state, Biochemistry, 50, 8202, 10.1021/bi200760h Figueroa, 2012, Modeling the interface between islet amyloid polypeptide and insulin-based aggregation inhibitors: Correlation to aggregation kinetics and membrane damage, J. Chem. Inf. Model., 52, 1298, 10.1021/ci300119c Mishra, 2013, Conformationally restricted short peptides inhibit human islet amyloid polypeptide (hIAPP) fibrillization, Chem. Commun. (Camb), 49, 2688, 10.1039/c3cc38982k Buchanan, 2013, Mechanism of IAPP amyloid fibril formation involves an intermediate with a transient β-sheet, Proc. Natl. Acad. Sci. U S A, 110, 19285, 10.1073/pnas.1314481110 Wang, 2014, A hIAPP-derived all-d-amino-acid inhibits hIAPP fibrillation efficiently at membrane surface by targeting α-helical oligomeric intermediates, FEBS Lett., 588, 884, 10.1016/j.febslet.2014.02.020 Patil, 2015, Charge-based inhibitors of amylin fibrillization and toxicity, J. Diabetes Res., 2015 Zhou, 2015, PEG modified graphene oxide loaded with EALYLV peptides for inhibiting the aggregation of hIAPP associated with type-2 diabetes, J. Mater. Chem. B, 3, 7055, 10.1039/C5TB00487J Shaykhalishahi, 2015, A β-hairpin-binding protein for three different disease-related amyloidogenic proteins, Chembiochem, 16, 411, 10.1002/cbic.201402552 Andreetto, 2015, A hot-segment-based approach for the design of cross-amyloid interaction surface mimics as inhibitors of amyloid self-assembly, Angew. Chem. Int. Ed. Engl., 54, 13095, 10.1002/anie.201504973 Kellock, 2016, Peptides composed of alternating l- and d-amino acids inhibit amyloidogenesis in three distinct amyloid systems independent of sequence, J. Mol. Biol., 428, 2317, 10.1016/j.jmb.2016.03.013 Sivanesam, 2017, Inhibition of human amylin amyloidogenesis by human amylin-fragment peptides: Exploring the effects of serine residues and oligomerization upon inhibitory potency, Biochemistry, 56, 5373, 10.1021/acs.biochem.7b00739 Mirecka, 2016, β-Hairpin of islet amyloid polypeptide bound to an aggregation inhibitor, Sci. Rep., 6, 10.1038/srep33474 Ghosh, 2015, Self-assembly of a nine-residue amyloid-forming peptide fragment of SARS corona virus E-protein: Mechanism of self aggregation and amyloid-inhibition of hIAPP, Biochemistry, 54, 2249, 10.1021/acs.biochem.5b00061 Obasse, 2017, Development of proteolytically stable N-methylated peptide inhibitors of aggregation of the amylin peptide implicated in type 2 diabetes, Interface Focus, 7, 10.1098/rsfs.2016.0127 Khemtemourian, 2017, Residue specific effects of human islet polypeptide amyloid on self-assembly and on cell toxicity, Biochimie, 142, 22, 10.1016/j.biochi.2017.07.015 Profit, 2017, Peptide conjugates of benzene carboxylic acids as agonists and antagonists of amylin aggregation, Bioconjugate Chem., 28, 666, 10.1021/acs.bioconjchem.6b00732 Sivanesam, 2016, Peptide inhibitors of the amyloidogenesis of IAPP: Verification of the hairpin-binding geometry hypothesis, FEBS Lett., 590, 2575, 10.1002/1873-3468.12261 Mao, 2017, New peptide inhibitors modulate the self-assembly of islet amyloid polypeptide residues 11-20 in vitro, Eur. J. Pharmacol., 804, 102, 10.1016/j.ejphar.2017.03.015 Mao, 2018, Design and study of lipopeptide inhibitors on preventing aggregation of human islet amyloid polypeptide residues 11−20, J. Pept. Sci., 24, 10.1002/psc.3058 Spanopoulou, 2018, Designed macrocyclic peptides as nanomolar amyloid inhibitors based on minimal recognition elements, Angew. Chem., Int. Ed. Engl., 57, 14503, 10.1002/anie.201802979 Shi, 2019, A novel pentapeptide inhibitor reduces amyloid deposit formation by direct interaction with hIAPP, Internet J. Endocrinol., 2019 Lin, 2019, Pentapeptide protects INS-1 cells from hIAPP-mediated apoptosis by enhancing autophagy through mTOR pathway, Front. Pharmacol., 10, 10.3389/fphar.2019.00896 Xin, 2019, Oligotyrosines inhibit amyloid formation of human islet amyloid polypeptide in a tyrosine-number-dependent manner, ACS Biomater. Sci. Eng., 5, 1092, 10.1021/acsbiomaterials.8b01384 Xuan, 2020, Monomer-targeting affinity peptide inhibitors of amyloid with no self-fibrillation and low cytotoxicity, Chem. Commun. (Camb), 56, 1633, 10.1039/C9CC08671D Bolarinwa, 2020, γ-AApeptides-based small molecule ligands that disaggregate human islet amyloid polypeptide, Sci. Rep., 10, 10.1038/s41598-019-56500-0 Paul, 2017, Disaggregation of amylin aggregate by novel conformationally restricted aminobenzoic acid containing α/β and α/γ hybrid peptidomimetics, Sci. Rep., 7, 10.1038/srep40095 Pithadia, 2016, Inhibition of IAPP aggregation and toxicity by natural products and derivatives, J. Diabetes Res., 2016 Levy, 2008, Phenolsulfonphthalein, but not phenolphthalein, inhibits amyloid fibril formation: Implications for the modulation of amyloid self-assembly, Biochemistry, 47, 5896, 10.1021/bi800043d Evers, 2009, Elucidating the mechanism of lipid membrane-induced IAPP fibrillogenesis and its inhibition by the red wine compound resveratrol: A synchrotron X-ray reflectivity study, J. Am. Chem. Soc., 131, 9516, 10.1021/ja8097417 Nedumpully-Govindan, 2016, Stabilizing off-pathway oligomers by polyphenol nanoassemblies for IAPP aggregation inhibition, Sci. Rep., 6, 10.1038/srep19463 Daval, 2010, The effect of curcumin on human islet amyloid polypeptide misfolding and toxicity, Amyloid, 17, 118, 10.3109/13506129.2010.530008 Cheng, 2011, Coffee components inhibit amyloid formation of human islet amyloid polypeptide in vitro: Possible link between coffee consumption and diabetes mellitus, J. Agric. Food Chem., 59, 13147, 10.1021/jf201702h Zelus, 2012, Myricetin inhibits islet amyloid polypeptide (IAPP) aggregation and rescues living mammalian cells from IAPP toxicity, Open Biochem. J., 6, 66, 10.2174/1874091X01206010066 Dubey, 2020, Myricetin protects pancreatic β-cells from human islet amyloid polypeptide (hIAPP) induced cytotoxicity and restores islet function, Biol. Chem., 402, 179, 10.1515/hsz-2020-0176 Cao, 2012, Analysis of the inhibition and remodeling of islet amyloid polypeptide amyloid fibers by flavanols, Biochemistry, 51, 2670, 10.1021/bi2015162 Young, 2014, Ion mobility spectrometry-mass spectrometry defines the oligomeric intermediates in amylin amyloid formation and the mode of action of inhibitors, J. Am. Chem. Soc., 136, 660, 10.1021/ja406831n Franko, 2018, Epigallocatechin gallate (EGCG) reduces the intensity of pancreatic amyloid fibrils in human islet amyloid polypeptide (hIAPP) transgenic mice, Sci. Rep., 8, 10.1038/s41598-017-18807-8 Cheng, 2012, Silibinin inhibits the toxic aggregation of human islet amyloid polypeptide, Biochem. Biophys. Res. Commun., 419, 495, 10.1016/j.bbrc.2012.02.042 Yang, 2019, Silibinin ameliorates amylin-induced pancreatic β-cell apoptosis partly via upregulation of GLP-1R/PKA pathway, Mol. Cell. Biochem., 452, 83, 10.1007/s11010-018-3414-9 Hagihara, 2012, Inhibitory effects of choline-O-sulfate on amyloid formation of human islet amyloid polypeptide, FEBS Open Bio, 2, 20, 10.1016/j.fob.2012.02.001 Paul, 2019, Molecular dynamics simulation study on the inhibitory effects of choline-O-sulfate on hIAPP protofibrilation, J. Comput. Chem., 40, 1957, 10.1002/jcc.25851 Bahramikia, 2013, Inhibition of human islet amyloid polypeptide or amylin aggregation by two manganese-salen derivatives, Eur. J. Pharmacol., 707, 17, 10.1016/j.ejphar.2013.03.017 Bruno, 2013, IAPP aggregation and cellular toxicity are inhibited by 1,2,3,4,6-penta-O-galloyl-β-d-glucose, Amyloid, 20, 34, 10.3109/13506129.2012.762761 Fortin, 2016, Discovery of ethyl urea derivatives as inhibitors of islet amyloid polypeptide fibrillization and cytotoxicity, Can. J. Physiol. Pharmacol., 94, 341, 10.1139/cjpp-2015-0204 Wu, 2017, Olive component oleuropein promotes β-cell insulin secretion and protects β-cells from amylin amyloid-induced cytotoxicity, Biochemistry, 56, 5035, 10.1021/acs.biochem.7b00199 Chaari, 2020, Inhibition of human islet amyloid polypeptide aggregation and cellular toxicity by oleuropein and derivatives from olive oil, Int. J. Biol. Macromol., 162, 284, 10.1016/j.ijbiomac.2020.06.170 Ren, 2018, Tanshinones inhibit hIAPP aggregation, disaggregate preformed hIAPP fibrils, and protect cultured cells, J. Mater. Chem. B, 6, 56, 10.1039/C7TB02538F Ben Hmidene, 2017, Inhibitory activities of antioxidant flavonoids from tamarix gallica on amyloid aggregation related to Alzheimer's and type 2 diabetes diseases, Biol. Pharm. Bull., 40, 238, 10.1248/bpb.b16-00801 Xin, 2018, Conformation-dependent manipulation of human islet amyloid polypeptide fibrillation by shiitake-derived lentinan, ACS Appl. Mater. Interfaces, 10, 31069, 10.1021/acsami.8b11078 Ren, 2018, Genistein: A dual inhibitor of both amyloid β and human islet amylin peptides, ACS Chem. Neurosci., 9, 1215, 10.1021/acschemneuro.8b00039 Azzam, 2018, Inhibition of human amylin aggregation and cellular toxicity by lipoic acid and ascorbic acid, Mol. Pharm., 15, 2098, 10.1021/acs.molpharmaceut.7b01009 Dubey, 2019, Azadirachtin inhibits amyloid formation, disaggregates pre-formed fibrils and protects pancreatic β-cells from human islet amyloid polypeptide/amylin-induced cytotoxicity, Biochem. J., 476, 889, 10.1042/BCJ20180820 Saravanan, 2019, The small molecule inhibitor anle145c thermodynamically traps human islet amyloid peptide in the form of non-cytotoxic oligomers, Sci. Rep., 9, 10.1038/s41598-019-54919-z Farrukh, 2019, Synthesis and identification of novel pyridazinylpyrazolone based diazo compounds as inhibitors of human islet amyloid polypeptide aggregation, Bioorg. Chem., 84, 339, 10.1016/j.bioorg.2018.11.039 Lao, 2019, Molecular Dynamics simulations reveal the inhibitory mechanism of dopamine against human islet amyloid polypeptide (hIAPP) aggregation and its destabilization effect on hIAPP protofibrils, ACS Chem. Neurosci., 10, 4151, 10.1021/acschemneuro.9b00393 Paul, 2019, Antagonistic activity of naphthoquinone-based hybrids toward amyloids associated with Alzheimer's disease and type-2 diabetes, ACS Chem. Neurosci., 10, 3510, 10.1021/acschemneuro.9b00123 Jiang, 2020, Inhibitory activities of kukoamines A and B from Lycii Cortex on amyloid aggregation related to Alzheimer's disease and type 2 diabetes, J. Nat. Med., 74, 247 Meng, 2020, Chitosan oligosaccharides attenuate amyloid formation of hIAPP and protect pancreatic β-cells from cytotoxicity, Molecules, 25, 10.3390/molecules25061314 Sun, 2020, Inhibitory activities of phenylpropanoids from Lycopus lucidus on amyloid aggregation related to Alzheimer’s disease and type 2 diabetes, J. Nat. Med., 74, 579 Mähler, 2013, Epigallocatechin-3-gallate: A useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases?, EPMA J., 4, 10.1186/1878-5085-4-5 Lee, 2019, Zinc boosts EGCG’s hIAPP amyloid Inhibition both in solution and membrane, Biochim. Biophys. Acta Protein Proteom., 1867, 529, 10.1016/j.bbapap.2018.11.006 Gurzov, 2016, Inhibition of hIAPP amyloid aggregation and pancreatic β-cell toxicity by OH-terminated PAMAM dendrimer, Small, 12, 1615, 10.1002/smll.201502317 Zhao, 2019, Ultraeffective inhibition of amyloid fibril assembly by nanobody-gold nanoparticle conjugates, Bioconjugate Chem., 30, 29, 10.1021/acs.bioconjchem.8b00797 Bai, 2019, Influence of fullerenol on hIAPP aggregation: Amyloid inhibition and mechanistic aspects, Phys. Chem. Chem. Phys., 21, 4022, 10.1039/C8CP07501H Yousaf, 2017, Fluorine functionalized graphene quantum dots as inhibitor against hIAPP amyloid aggregation, ACS Chem. Neurosci., 8, 1368, 10.1021/acschemneuro.7b00015 Wang, 2017, Differential effects of silver and iron oxide nanoparticles on IAPP amyloid aggregation, Biomater. Sci., 5, 485, 10.1039/C6BM00764C Nedumpully-Govindan, 2016, Graphene oxide inhibits hIAPP amyloid fibrillation and toxicity in insulin-producing NIT-1 cells, Phys. Chem. Chem. Phys., 18, 94, 10.1039/C5CP05924K Bai, 2020, Pristine and hydroxylated fullerenes prevent the aggregation of human islet amyloid polypeptide and display different inhibitory mechanisms, Front. Chem., 8, 10.3389/fchem.2020.00051 Xu, 2021, Procyanidine resists the fibril formation of human islet amyloid polypeptide, Int. J. Biol. Macromol., 183, 1067, 10.1016/j.ijbiomac.2021.05.030 Faridi, 2019, Graphene quantum dots rescue protein dysregulation of pancreatic β-cells exposed to human islet amyloid polypeptide, Nano Res., 12, 2827, 10.1007/s12274-019-2520-7 Ilitchev, 2018, Zinc-induced conformational transitions in human islet amyloid polypeptide and their role in the inhibition of amyloidosis, J. Phys. Chem. B, 122, 9852, 10.1021/acs.jpcb.8b06206 Salamekh, 2011, A two-site mechanism for the inhibition of IAPP amyloidogenesis by zinc, J. Mol. Biol., 410, 294, 10.1016/j.jmb.2011.05.015 Brender, 2010, Role of zinc in human islet amyloid polypeptide aggregation, J. Am. Chem. Soc., 132, 8973, 10.1021/ja1007867 Rivillas-Acevedo, 2015, Structural basis for the inhibition of truncated islet amyloid polypeptide aggregation by Cu(II): Insights into the bioinorganic chemistry of type II diabetes, Inorg. Chem., 54, 3788, 10.1021/ic502945k Wang, 2017, Inhibition of amyloid peptide fibril formation by gold-sulfur complexes, J. Inorg. Biochem., 171, 1, 10.1016/j.jinorgbio.2017.02.021 Wu, 2017, Strong inhibitory effect of heme on hIAPP fibrillation, Chem. Res. Toxicol., 30, 1711, 10.1021/acs.chemrestox.7b00170 Gong, 2019, Influence of methionine-ruthenium complex on the fibril formation of human islet amyloid polypeptide, J. Biol. Inorg. Chem., 24, 179, 10.1007/s00775-019-01637-6 Gong, 2018, Regulation of heteronuclear Pt-Ru complexes on the fibril formation and cytotoxicity of human islet amyloid polypeptide, J. Inorg. Biochem., 189, 7, 10.1016/j.jinorgbio.2018.08.012 He, 2014, Inhibition of human amylin fibril formation by insulin-mimetic vanadium complexes, Metallomics, 6, 1087, 10.1039/C4MT00021H Zhang, 2020, Peroxynitrite scavenger FeTPPS effectively inhibits hIAPP aggregation and protects against amyloid induced cytotoxicity, Int. J. Biol. Macromol., 161, 336, 10.1016/j.ijbiomac.2020.06.034 Gao, 2015, Modulation of human IAPP fibrillation: Cosolutes, crowders and chaperones, Phys. Chem. Chem. Phys., 17, 8338, 10.1039/C4CP04682J Montane, 2017, Amyloid-induced β-cell dysfunction and islet inflammation are ameliorated by 4-phenylbutyrate (PBA) treatment, Faseb. J., 31, 5296, 10.1096/fj.201700236R Fernández-Gómez, 2018, Diabetes drug discovery: hIAPP1-37 polymorphic amyloid structures as novel therapeutic targets, Molecules, 23, 10.3390/molecules23030686